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Reprocessing, CDC, and IPs:
LEVERAGING PUBLIC HEALTH SERVICES AND RESOURCES FOR STERILIZATION AND 
HIGH-LEVEL DISINFECTION OF MEDICAL DEVICES
MATTHEW J. STUCKEY, PhD, MPH, ISAAC BENOWITZ, MD
Matthew Stuckey, PhD, MPH, and Isaac Benowitz, MD, are both with the Division of Healthcare 
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Sterilization and high-level disinfection (HLD) are highly technical processes informed by 
standards and guidelines. Improper reprocessing of medical devices puts patients at risk for 
healthcare-associated infections (HAIs), including those caused by bloodborne and bacterial 
pathogens. Commonly observed problems include failure to adhere to standards, guidelines, 
and manufacturer instructions for use; lack of understanding about how to monitor and 
interpret various quality indicators (e.g., sterilization parameters and controls); and 
complicated designs that make devices (e.g., some duodenoscopes) difficult to properly 
clean and disinfect. Adherence to best practices in the reprocessing of medical devices is a 
Standard Precaution and essential to facility HAI prevention and occupational health 
programs.
Local, state, and federal public health organizations provide important contributions to 
sterilization and HLD practices. The Centers for Disease Control and Prevention (CDC), in 
collaboration with local and state partners, provides a number of services and resources for 
reprocessing activities. In this article, we highlight select CDC resources and review CDC 
consultations on the reprocessing or reuse of medical devices.
BACKGROUND
The reprocessing of medical devices (sometimes referred to as medical instruments, 
equipment, or tools) requires trained personnel who can competently and consistently 
perform multistep tasks encompassing cleaning and decontamination, HLD, preparation and 
packing, sterilization, storage and transport, and quality assurance. The appropriate method 
of reprocessing is informed by the Spaulding Classification, which defines the minimum 
level of disinfection or sterilization that should be employed for types of devices.1 The 
system is divided into three categories:
• Critical devices that enter normally sterile tissue or the vascular system require 
sterilization.
• Semi-critical devices that come into contact with mucous membranes or non-
intact skin require HLD or sterilization.
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• Noncritical devices that contact only intact skin require low- to intermediate-
level disinfection.
Reprocessing programs should be structured to meet the needs of different healthcare 
services (e.g., surgery, endoscopy, dentistry, podiatry) and may be managed internally within 
facilities or outsourced to off-site reprocessing services.
A wide range of resources is available to help healthcare facilities conduct internal or 
external assessments of reprocessing performance. Regular review of policies and 
procedures is considered a best practice and can be performed as part of accreditation and 
certification programs.
APPLICABLE STANDARDS, GUIDELINES, AND REGULATIONS
Duties performed by reprocessing managers and technicians are informed by a number of 
standards and guidelines, including those developed by the Association for the Advancement 
of Medical Instrumentation (AAMI) and adopted by the American National Standards 
Institute (ANSI). ANSI/AAMI standards pertinent to sterilization and HLD include:
• ANSI/AAMI ST79:2017: Comprehensive guide to steam sterilization and 
sterility assurance in health care facilities
• ANSI/AAMI ST58:2013/(R)2018: Chemical sterilization and high-level 
disinfection in health care facilities
• ANSI/AAMI ST9L2015: Flexible and semi-rigid endoscope processing in 
healthcare facilities
• AAMI TIR34:2014/(R)2017: Water for the reprocessing of medical devices
Other professional organizations such as the Association of periOperative Registered Nurses 
(AORN) and the Association for Professionals in Infection Control and Epidemiology 
(APIC) also provide guidance on best practices.
In the United States, reprocessing is subject to state and federal laws and regulations. At the 
federal level, both the Environmental Protection Agency (EPA) and the Food and Drug 
Administration (FDA) participate in the regulatory framework for disinfectants and 
sterilants.1 FDA also regulates medical devices such as sterilizers and automated endoscope 
reprocessors.
CDC AND REPROCESSING
Public health organizations are important stakeholders in sterilization and HLD practices as 
a function of their work in HAI prevention and healthcare worker safety. CDC provides a 
number of services and resources pertinent to medical device reprocessing, including but not 
limited to the following:
• Guidance and protocols to help define practices
• Tools, checklists, and trainings to assist with implementation
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• Consultation and other technical assistance to facilities and health departments to 
identify and address gaps
CDC healthcare infection control guidelines were developed with input from the Healthcare 
Infection Control Practices Advisory Committee (HICPAC), including representatives of 
APIC and other organizations with expertise in infection prevention and control (IPC), 
HAIs, epidemiology, policy, and related fields. Regulatory authorities and healthcare 
systems may require that facility policies align with CDC guidelines.
CDC works with health departments and other federal agencies to promote patient safety 
and respond to outbreaks in healthcare facilities. Additionally, all state health departments 
have CDC-supported HAI programs that support IPC efforts in facilities in their respective 
jurisdictions. CDC routinely provides remote consultation and laboratory support for 
facilities and health departments investigating HAI outbreaks or infection control breaches, 
including breaches serious enough to warrant patient notification. At the request of state and 
local partners, CDC may also provide on-site technical assistance, with activities ranging 
from epidemiological investigations to assessments of IPC. The CDC National Institute for 
Occupational Safety and Health (NIOSH) performs research on and provides technical 
assistance with workplace hazards and the use of personal protective equipment. When 
adverse events occur, it is important to comprehensively assess and correct as quickly as 
possible any associated gaps in training, monitoring, policies, or practices.
In 2016, state and local public health departments conducted an HAI outbreak response 
capacity self-assessment, and 58% of responding jurisdictions indicated that their HAI 
program would benefit from additional investigation forms, tools, and training materials 
related to reprocessing errors.2 To support investigations and assessments in healthcare 
facilities, CDC creates freely available products such as tools and checklists that can be used 
by infection preventionists (IPs) and other public health professionals. A number of these 
products are specifically targeted toward or contain components related to medical device 
and instrument reprocessing. CDC also provides opportunities for continuing education 
through in-person trainings and online webinars with content encompassing sterilization and 
HLD.
IPS AND REPROCESSING
Following recommended sterilization and HLD practices is essential to a facility HAI 
prevention program.3 As such, the IP is increasingly recognized to have a critical role in 
reprocessing. IPs can champion IPC by guiding medical device and equipment acquisition, 
consulting on facility design for new or remodeled reprocessing spaces, improving and 
implementing processes, and performing assessments and quality assurance.4
However, many IPs lack formal training in sterilization and HLD practices. The 2015 APIC 
MegaSurvey reported that 82% of IPs came from a background in clinical nursing, which 
may not provide exposure to many of the technical aspects of reprocessing programs.5 
Employees responsible for sterilization and HLD can pursue professional certifications to 
demonstrate competency in all aspects of reprocessing. Adult learning encompassing 
declarative and procedural knowledge is another supported paradigm for encouraging on-
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the-job education in these programs.6 IPs can use these formal and informal training 
mechanisms to expand their working technical knowledge of reprocessing practices.
CDC SERVICES AND RESOURCES
In the following sections, we summarize CDC services and resources related to medical 
device reprocessing (see also Table 1), and we draw from our review of internal records of 
CDC responses and consultations from 2017 to highlight selected issues in recent reports of 
infection control concerns regarding the reprocessing or reuse of medical devices.
Guidance, statements, and protocols
Rutala, Weber, and HICPAC authored the comprehensive CDC Guideline for Disinfection 
and Sterilization in 2008 (Table 1.1). This evidence-based guideline has received several 
updates, most recently in 2017.
HICPAC recommendations are also available for the essential elements of a reprocessing 
program for flexible endoscopes (Table 1.2). Surveillance sampling and culturing protocols 
are available for duodenoscopes from FDA, CDC, and the American Society for 
Microbiology (Table 1.3).
Infection control guidelines for specific settings are available for dentistry (Table 1.4, 1.5) 
and podiatry (Table 1.6). CDC also funded external partners to create the best-practice 
guide, Using the Health Care Physical Environment to Prevent and Control Infection, which 
contains a chapter on reprocessing spaces (Table 1.7).
Consultation, response, and other technical assistance
CDC’s Division of Healthcare Quality Promotion documented 285 consultations and 
responses related to HAI or IPC concerns with a date of first contact from January 1 to 
December 31, 2017. Of these, 48 (17%) were determined to involve an infection control 
concern specifically related to the reprocessing or reuse of medical devices. Thirty of the 48 
reprocessing/reuse issues (63%) involved an acute care hospital and nine (19%) a specialty 
clinic.
Investigations identified infections including those caused by devices contaminated in 
manufacturing, deficient reprocessing of endoscopes or ventilators, and inappropriate device 
use or reuse. Actions included device recalls, improved infection control and device 
reprocessing, and patient notification and testing. While CDC is sometimes consulted about 
HAI and IPC concerns related to reprocessing, many investigations of HAI outbreaks and 
serious IPC breaches are handled at the state or local level without CDC involvement.
CDC has also performed on-site assessments of sterilization and HLD practices under the 
jurisdiction of state and local health departments and other federal partners. Recent 
examples of observed deficiencies included:
• Limited physical spaces in reprocessing areas
• Lack of adherence to a unidirectional flow from dirty to clean processes
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• Insufficient air exchange rates
• Lack of understanding about how to monitor and interpret various quality 
indicators (e.g., sterilization parameters and controls)
• Inadequate documentation of manufacturer instructions for use
CDC provides contact information for general inquiries (Table 1.8). Facilities identifying an 
IPC breach or HAI outbreak concern are encouraged to contact their state or local health 
department for assistance (Table 1.9).
CDC NIOSH offers on-site support in the form of Health Hazard Evaluations, which 
specifically evaluate possible health hazards in the workplace (Table 1.10).
Tools, checklists, and trainings
A number of practical assessment materials encompassing sterilization and HLD are 
available from CDC. The Infection Control Assessment and Response (ICAR) tools (Table 
1.11) were developed to assist health departments in assessing IPC practices and guide 
quality improvement activities. ICAR tools may also be used by IPs for internal quality 
improvement audits and have sections specific to reprocessing across a variety of healthcare 
settings.
There are additional CDC tools for dental settings, including checklists (Table 1.12), mobile 
apps (Table 1.13), and safe care training modules (Table 1.14).
CDC also partnered with APIC to develop quick observation tools for infection prevention, 
which include forms for assessing HLD clean and dirty areas (Table 1.15).
CONCLUSION
IPs are increasingly recognized to have a critical role in reprocessing programs at healthcare 
facilities. Given their responsibilities, IPs are well positioned to employ CDC services and 
resources to strengthen their own competencies in sterilization and HLD, and serve as 
important links with public health organizations. We recommend that IPs become familiar 
with CDC activities related to the reprocessing of medical devices. Awareness of the 
highlighted CDC resources is beneficial for strengthening the ongoing partnerships between 
public health and healthcare facilities.
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